Steven R. Patierno, Ph.D.

Duke Cancer Institute

Joining Duke in 2012, Dr. Patierno serves as Deputy Director of the Duke Cancer Institute, Professor of Medicine, Professor of Pharmacology and Cancer  Biology, and Professor of Community and Family Medicine, and as Director of Cancer Control, Healthcare Delivery and Population Sciences, as well as Cancer Supportive Care and Survivorship Services. Prior to joining Duke, Dr.Patierno served as Executive Director of The George Washington University Cancer Center, the Vivian Gill Distinguished Professor of Oncology and Professor of Pharmacology and Physiology, Genetics and Urology in the GWU School of Medicine and Health Sciences. His prior training includes a B.S. in Pharmacy from the University of Connecticut, a PhD in molecular pharmacology from the Graduate School of Biomedical Science, University of Texas Health Science Center-MD Anderson Cancer Institute in Houston Texas, and an NIH-funded postdoctoral fellowship at the University of Southern California (USC) Norris Comprehensive Cancer Center in molecular oncology and carcinogenesis. Dr.Patierno’s basic science and translational research laboratory has been funded continuously by the NIH, the NCI and Department of Defense for nearly 25 years and he has published more than 130 peer-reviewed cancer research papers on molecular carcinogenesis, metastasis, cancer pharmacology and most recently on the genomics, epigenomics, transcriptomics and biology of cancer disparities. In addition, he has led a number of large, multi-institutional, patient-centered, community-based and cancer healthcare delivery grants from the NCI, CDC, numerous foundations, industry, and the DC Cancer Consortium addressing cancer disparities, patient navigation, prevention, control, education, outreach, and survivorship. This includes serving as PI to the DC arm of the NCI-funded, multi-institutional Patient Navigation Research Program, and DC City-wide Patient Navigation Network.The Duke Cancer Institute is a top-ranked NCI-designated Comprehensive Cancer Center dedicated to providing leading-edge compassionate care from diagnosis to treatment to survivorship, advancing multi- and trans-disciplinary cancer research across the full cancer research continuum, and engaging in authentic prevention and community health programming. DCI is one of the original eight NCI-designated comprehensive cancer centers, with more than 75,000 patient visits and 7500 new cancer diagnoses annually, with nearly 1000 active clinical trials. DCI includes more than 350 investigators with more than $250 million in annual cancer research funding.

Ed Partridge, MD

University of Alabama at Birmingham

Edward E. Partridge, MD, is Director Emeritus and Distinguished Professor at the University of Alabama at Birmingham Comprehensive Cancer Center. He served as Director of the UAB Comprehensive Cancer Center and holder of the Evalina B. Spencer Chair in Oncology from 2007 to 2017. He was Professor of Obstetrics and Gynecology from 1996 to 2017 and former Director of the Division of Gynecologic Oncology. His clinical interests are cancer control and prevention; cervical cancer; community based participatory research; gynecologic oncology; and minority health disparities. He was principal investigator of the Deep South Network for Cancer Control (NCI) which utilizes Community Health Advisors to improve the cancer health status of t he African-American population in the rural South. He was PI of the Morehouse School of Medicine/Tuskegee University/UAB Cancer Center Partnership to enhance the research capability of the minority-serving institutions and the ability of the Cancer Center to conduct cancer disparity research. He also served as PI of the UAB component of the Cervical Cancer SPORE at Johns Hopkins. Dr. Partridge currently serves as Medical Director of the UAB Health System Cancer Community Network that utilizes lay navigators across the continuum of cancer care, a part of Cancer Care Connect, a CMS funded project. He also served as t he co-director of the UAB Minority Health & Health Disparities Research Center from 2002 to 2017. In 2010-2011 Dr. Partridge served as President of the National Board of the American Cancer Society. He was previously Chairman of the Commission on Cancer for the American College of Surgeons. He is on the Board of Directors of the Mid-South Division of the American Cancer Society. Dr. Partridge has received numerous awards and honors throughout his career, including the UAB Distinguished Alumni Award, UAB President’s Excellence in Teaching Award from the School of Medicine, the Distinguished Faculty Award from the Comprehensive Cancer Center and the Academic Health Center and UAB’s highest honor–the Distinguished Faculty Lecturer Award. Outside of UAB, he has been honored with the St. George’s Medal for Contributions to Cancer Control from the American Cancer Society, the Birmingham Business Journal’s 2009 Health Care Heroes physician provider award, and recently was honored with the American Cancer Society’s prestigious 2013 National Humanitarian Award.

Nina Miller, MSSW, OSW‐C

American College of Surgeons Commission on Cancer

Nina Miller is a graduate of the University of Wisconsin’s School of Social Work. Nina’s clinical practice as an oncology social worker spanned over 15 years in the acute and outpatient settings. She completed a fellowship in the Office of Cancer Communications at the National Cancer Institute and managed NCI’s Cancer Information Service in their regional field office at the University of Wisconsin’s Comprehensive Cancer Center. During her years at the American Cancer Society, Nina was Director of Patient Services for the Midwest Division and served on several national work groups. Nina is currently the American College of Surgeon’s Commission on Cancer Manager, Cancer Initiatives.

Leslie Hardy, MHS

Merck Foundation

Leslie M. Hardy is executive vice president of the Merck Foundation (Merck & Co.,Inc., Kenilworth, NJ,USA). She leads the Foundation’s program portfolio in the areas of public health, health care quality and policy, both in the U.S. and internationally. Program investments focus on improving the quality and delivery of health care, strengthening health systems, increasing access to care and promoting health equity among vulnerable populations across the following selected disease areas:Alzheimer’s disease, cancer, diabetes, hepatitis C and HIV/AIDS. Ms. Hardy has responsibility for health program strategy and evaluation, partnership development, communications and operations; she also currently leads the Merck Foundation’s initiatives to address non-communicable diseases, including: the Alliance to Advance Patient-Centered Cancer Care and Bridging the Gap: Reducing Disparities in Diabetes Care. Prior to joining Merck, Ms. Hardy served as Senior Policy Analyst and Special Assistant to the Assistant Secretary of Planning and Evaluation (ASPE) in the U.S. Department of Health and Human Services, where she coordinated key policy and program initiatives in global infectious diseases, HIV/AIDS and women’s health. She also developed and directed a number of public health policy and HIV/AIDS project during her tenure at the Institute of Medicine(now National Academy of Medicine) of the National Academy of Sciences. Ms. Hardy is a graduate of Duke University, and holds a Master of Health Science in public health from The Johns Hopkins Bloomberg School of Public Health.

Sharon Gentry, RN, MSN, ONN-CG, AOCN, CBCN, CBEC

Novant Health

Ms. Gentry is part of an ongoing successful breast nurse navigator program at the Novant Health Derrick L. Davis Cancer Center. She is an interdisciplinary team member connecting 2 hospitals, a breast mammography clinic, a regional cancer center, a community surgical office and a variety of community resources in Winston-Salem, NC. She received her bachelor’s degree in nursing at the University of North Carolina at Chapel Hill and her master’s degree in nursing education at the University of North Carolina at Greensboro. She has been a member of the Academy of Oncology Nurse and Patient Navigators Leadership Council since its inception in 2009 and speaks at their annual and regional conferences on nurse navigation issues. In 2012-2017, she co-chaired the annual AONN+ conferences.She serves on the editorial board of The Oncology Nurse-APN/PA and CONQUER and is the breast editor for the Journal of Oncology Navigation & Survivorship (JONS). She has authored articles in JONS, Cancer, The Oncology Nurse-APN/PA, Journal of Psychosocial Oncology, and CONQUER as well as authored chapters in the books Delivering Patient-Centered Care Across the Continuum and Nurse Navigation Case Studies. She has been a member of the Oncology Nursing Society since 1983. She was a founding member of the Piedmont Triad Oncology Nurse Chapter in 1988 and has served in a leadership role since its inception. She was a participant on the inception of the Oncology Nursing Certified Breast Care Nurse examination and chaired the Oncology Nursing Certification Breast Care Committee 2010-2012. She holds certification as Oncology Nurse Navigation Generalist Certification, Certified Breast Care Nurse, Advanced Oncology Practice Nurse, and Clinical Breast Examination Certified. On nursing navigation commitment, she assisted in organizing the state navigation association—North Carolina Oncology Navigator Association as well as participated on the Standardized Navigation Metrics Task Force, under the AONN+ Evidence into Practice Committee, and assisted in the development of the 35-national evidence-based navigation metrics that all navigation programs—no matter the model of navigation chosen—can utilize to measure success and sustainability of their program. Ms. Gentry travels nationally lecturing on the navigation concept. On the local level, she is a Northwest North Carolina Susan G. Komen volunteer, serves on the board of the local hospice and participates in the Derrick L. Davis Forsyth Regional Cancer Center Oncology Breast Advisory Committee.

Karen M. Freund, MD, MPH

Tufts Medical Center, Tufts University School of Medicine

Dr. Karen Freund is an American Cancer Society Clinical Research Professorship. She is Vice Chair of Medicine at Tufts Medical Center and Professor of Medicine at Tufts University School of Medicine. Trained as a primary care provider who continues to see her own patients, Dr. Freund has broad understanding of the clinical issues in cancer prevention, care and survivorship. Her research focuses on cancer prevention and control and addressing cancer health disparities. She served as one of the leaders of the NCI and ACS -funded national Patient Navigation Research Program, a multi-site trial investigating the ability of patient navigation to reduce cancer health disparities. This research team demonstrated the broad impact of patient navigation to improve timely and quality care to patients. The research specifically demonstrated that patient navigation can reduce health disparities, closing the gap in quality and timely care for minority patients, low income patients and other vulnerable populations.

Linda Fleisher, PhD, MPH

The Children’s Hospital of Philadelphia Research Institute

Dr. Fleisher PI, is a Senior Scientist and Associate Research Professor with a focus on health communications, patient engagement and use of technology to support patients and their families. She has appointments in the Research Institute at the Children’s Hospital of Philadelphia, Perelman School of Medicine, Department of Pediatrics, University of Pennsylvania and the Fox Chase Cancer Center. She has considerable experience in behavioral research, health education, development and evaluation of Ehealth and Mhealth interventions, health disparities and patient/community engagement. She was the Project Director and Principal Investigator for the NCI’s Cancer Information Service in the tri-state area for over 17 years, serving over ½ million callers with in-depth information and resources addressing the continuum of cancer prevention, risk, detection, treatment and survivorship. She also founded Fox Chase Cancer Center’s Patient Resource Education Center in 2000, which is one of the first multi-media patient education programs at a comprehensive cancer center, serving over 30,000 people. The REC includes a LiveHelp online program for patients and consumers to ask questions with trained health educators and listings of recommended websites that are evaluated using a scientifically developed tool. She led the development of numerous patient education and decision making interventions for cancer patients and survivors as well as a current study focused on informed decision making in clinical trials. She has developed technical guides on health literacy and patient navigation for professionals and brings these skills and knowledge to the development of patient education tools and resources. Her work has required building networks and partnerships with diverse audiences, including health care organizations, software developers, patients, and community leaders, including a tri-state health disparities network under the NCI’s Cancer Information Service and the current Cancer Health Disparities Network serving 19 states. She was Co-PI on the Pennsylvania Patient Navigation Demonstration Project and co-founder of the PA Navigator Network. She has served as member of the Academy of Oncology Nurse and Patient Navigator’s Steering Committee since 2010, and is the co-chair of the Technology and Innovation Committee. She joined the faculty at Children’s Hospital of Philadelphia and is leveraging her extensive background in health communications, digital health and partnerships to lead a digital health initiative focused on translating knowledge of evaluation and evidence to health app developers, distributors and consumers to ensure that the explosion of mobile health tools are evidence-based and their impact on health improvement are validated.

Elizabeth Calhoun, PhD, MEd

University of Arizona

Dr. Calhoun, PhD MEd, is currently the Associate Director of Population Sciences at the University of Arizona Cancer Center. In addition, she is the Executive Director for the Center for Population Science and Discovery. She was the Director of the Center of Excellence in Eliminating Disparities funded by NIMHD and the Co-Director for the Center for Population Health and Health Disparities funded by NCI at the University of Illinois at Chicago. In addition, she was the principal investigator of an NCI-funded study to test the efficacy of a patient navigation program on improving compliance with cancer care in the largest network of federally qualified health centers in the country. She is an experienced health services researcher with expertise in health disparities. She was a member of the Commission on Cancer standards committee that requires community assessment and patient navigation services for accreditation. She has lead the Illinois training for navigators and certified application counselors and evaluation for the implementation of the Affordable Care Act (ACA) in Illinois from 2013-2016. Mostly, she was an editor of a book entitled Patient Navigation- Overcoming Barriers to Care, which offers a practical guide to creating, implementing and evaluating successful programs.

Linda Burhansstipanov, MSPH, DrPH

Native American Cancer Research Corporation

Linda Burhansstipanov, (Cherokee Nation) has worked in public health since 1971. She taught at universities for 18 years (California State University Long Beach and UCLA). She developed and implemented the Native American Cancer Research Program at the National Cancer Institute from 1989-1993. She worked at the AMC Cancer Research Center in Denver for 5 years before founding Native American Cancer Research Corporation (non-profit). She also is the President of Native American Cancer Initiatives, Incorporated (minority womans for-profit). She is the principal investigator and subcontractor for >3 NIH grants and PI for a NIMHD 2017 Phase I SBIR to develop a tablet app to evaluate Patient Navigation Services. She also is on the NIMHD Scientific Advisory Council. She serves on multiple federal advisory boards. She has over 125 peer-reviewed publications, of which most address Native American cancer, genetics, CBPR, evaluation, patient navigation, survivorship, public health and data issues.

Harold P. Freeman, MD

Harold P. Freeman Patient Navigation Institute

Honorary Chair

National Navigation Roundtable Harold P. Freeman, M.D. is president and CEO of the Harold P.Freeman Patient Navigation Institute in New York City. He is Professor of Surgery Emeritus, Columbia University and previously served as Director of Surgery at Harlem Hospital and Professor of Clinical Surgery at Columbia University College of Physicians and Surgeons. Dr. Freeman is a diplomat of the American Board of Surgery and a Fellow of the American College of Surgeons. He is also a member of the Institute of Medicine of the National Academy of Sciences. Dr. Freeman is founder and Chairman Emeritus of the Ralph Lauren Center for Cancer Care and Prevention and founder and Medical Director of the Breast Examination Center of Harlem, a program of Memorial Sloan-Kettering Cancer Center. He was the first director of the National Cancer Institute (NCI) Center to Reduce Cancer Health Disparities and served as Associate Director of the NCI for a five-year period ending in 2005. He served as national president of the American Cancer Society in 1988-89 and he was the chief architect of the American Cancer Society’s initiative on Cancer in the Poor.

The American Cancer Society established the Dz Harold P. Freeman Award dz in 1990 to recognize his work in this area. Dr. Freeman pioneered the patient navigation concept and model which addresses disparities in access to timely diagnosis and treatment, particularly among poor and uninsured people. Based on this model the Patient Navigator and Chronic Disease Prevention Act was signed into law by President Bush in 2005. Dr. Freeman was appointed by Presidents George Bush and Clinton to serve as Chairman of the United States President’s Cancer Panel for an 11-year period.

He is a Lasker Laure ate, and received the Lasker Award for Public Service in 2000 for Dz enlightening scientists and the public about the relation-ship between race, poverty and cancer”. In 2015, Dr. Freeman was named a “Giant of Cancer Care” by OncLive.